EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Prophylactic Left Atrial Appendage Occlusion During Mitral Valve Repair in Patients Without Atral Fibrillation: A Meta‐Analysis of Time to Event Data

Ahmed Emara iD, Ameer Awashra iD, Mohamed S Elgendy iD, Mohamed R Murad, Mohamed Emara, Abubakar Nazir, Abdalhakim Shubietah iD, Michael Megaly, Vinayak N Bapat

Journal of Arrhythmia · 2026-06 · 42 (3)

DOI: 10.1002/joa3.70355 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Arrhythmia, online erschienen am 03.05.2026. Verfasst von Ahmed Emara und 8 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine Al-Azhar University Cairo Egypt. Die Arbeit nennt 11 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Mitral valve repair (MVr) is effective for mitral regurgitation, but the benefit of prophylactic left atrial appendage occlusion (LAAO) in patients without prior atrial fibrillation (AF) remains unclear. This meta‐analysis aimed to assess the long‐term safety and efficacy of LAAO in this understudied population.

Methods

We performed a meta‐analysis from four major databases until December 2025. Kaplan–Meier curves data were reconstructed and analyzed using Cox regression models and hazard ratios (HR) for thromboembolic events (mainly stroke). A random‐effects meta‐analysis was performed with R software to calculate risk ratios (RR), hazard ratios (HR), and mean differences (MD), all with 95% confidence intervals (CIs).

Results

Three studies with 5048 patients were included. LAAO was associated with a significant reduction in thromboembolic risk at 5 years (HR 0.60, 95% CI 0.46 to 0.77). LAAO reduced in‐hospital stroke (RR 0.43, 95% CI 0.25 to 0.72) but increased postoperative AF (RR 1.17, 95% CI 1.09 to 1.26). No significant differences were observed in 30‐day mortality (RR 0.56, 95% CI 0.07 to 4.33) or hospital stay (MD –0.16 days, 95% CI – 0.48 to 0.16).

Conclusions

Prophylactic LAAO during MVr in patients without AF may reduce thromboembolic events risk but appears to increase postoperative AF. Further randomized studies are warranted.

Schlagwörter

Stichwörter der Autor:innen

atrial fibrillationleft atrial appendage occlusionmitral valve repair

Autor:innen und Institutionen

  • Faculty of Medicine Al-Azhar University Cairo Egypt.
  • Department of Medicine An Najah National University Nablus Palestine.
  • Faculty of Medicine Tanta University Tanta Egypt.
  • Department of Medicine Mercy Health-The Jewish Hospital Cincinnati Ohio USA.
  • Department of Medicine Advocate Illinois Masonic Medical Center Chicago Illinois USA.
  • Integris Health Heart Hospital Oklahoma City Oklahoma USA.

ORCID-Profile: Ahmed Emara, Ameer Awashra, Mohamed S Elgendy, Abdalhakim Shubietah

Zitieren

APA

Emara, A., Awashra, A., Elgendy, M. S., Murad, M. R., Emara, M., Nazir, A., Shubietah, A., Megaly, M., & Bapat, V. N. (2026). Prophylactic Left Atrial Appendage Occlusion During Mitral Valve Repair in Patients Without Atral Fibrillation: A Meta‐Analysis of Time to Event Data. Journal of Arrhythmia, 42(3). https://doi.org/10.1002/joa3.70355

Vancouver

Emara A, Awashra A, Elgendy MS, Murad MR, Emara M, Nazir A, et al. Prophylactic Left Atrial Appendage Occlusion During Mitral Valve Repair in Patients Without Atral Fibrillation: A Meta‐Analysis of Time to Event Data. Journal of Arrhythmia. 2026;42(3). doi:10.1002/joa3.70355

BibTeX
@article{Emara2026,
  author = {Emara, Ahmed and Awashra, Ameer and Elgendy, Mohamed S and Murad, Mohamed R and Emara, Mohamed and Nazir, Abubakar and Shubietah, Abdalhakim and Megaly, Michael and Bapat, Vinayak N},
  title = {Prophylactic Left Atrial Appendage Occlusion During Mitral Valve Repair in Patients Without Atral Fibrillation: A Meta‐Analysis of Time to Event Data},
  journal = {Journal of Arrhythmia},
  year = {2026},
  volume = {42},
  number = {3},
  doi = {10.1002/joa3.70355}
}
Kostenlos starten →